Scarica l'app Stockscreener
233.33
0.97%
2.24
Dopo l'orario di chiusura:
233.33
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Quest Diagnostics Inc Borsa (DGX) Ultime notizie
Quest Diagnostics (DGX) Highlights Haystack MRD Test Accuracy in Colorectal Cancer Trials - GuruFocus
Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Quest Diagnostics Stock Gains 36.3% YTD: What's Behind the Rally? - TradingView
Global Paternity & Relationship Testing Services Market Set for Growth Through 2030 as DNA Testing Demand Expands Across Applications and Product Segments - GlobeNewswire Inc.
Quest Diagnostics (DGX) Could Be 5% Below Fair Value After Apple Health Launch - Yahoo Finance
Quest Diagnostics shows growth potential despite Medicare uncertainties, driven by testing demand and acquisitions. - Pluang
Quest Diagnostics Incorporated: Testing Growth Keeps Me Bullish Despite Medicare Headwinds - Seeking Alpha
Quest Diagnostics Inc (DGX) Stock Down 4.1% but Still Overvalued -- GF Score: 74/100 - GuruFocus
Quest Diagnostics (DGX) Stock Could Be 30% Below Fair Value Following Medicare Payment Cut Concerns - Yahoo Finance
Quest Diagnostics to Release Third Quarter Financial Results on October 22, 2026 - Yahoo Finance
Quest Diagnostics Study Finds High Tick-Borne Disease Co-Exposure - Zacks Investment Research
Why Quest Diagnostics Holdings Stock Dropped Today - Yahoo Finance
Quest Diagnostics, Labcorp Shares Fall as Medicare Signals Cuts in Payment Rates for Lab Services - marketscreener.com
Is This the Right Time to Add DGX Stock to Your Portfolio? - TradingView
Is Quest Diagnostics Stock Outperforming the Nasdaq? - inkl
Evercore sees Lab Corp, Quest shares facing Medicare pricing headwind By Investing.com - Investing.com Canada
Baird Adjusts Price Target on Quest Diagnostics to $260 From $255, Maintains Neutral Rating - marketscreener.com
Labcorp, Quest fall as CMS cuts 2027 rates for laboratory services (LH:NYSE) - Seeking Alpha
Quest Diagnostics Sees Growth Outpace Targets as Consumer Testing Surges - Yahoo Finance
Nearly 1 in 3 people with Lyme antibodies had others too. A parasite found alongside Lyme needs different treatment. - Stock Titan
Truist Raises Price Target on Quest Diagnostics to $260 From $250, Keeps Hold Rating - marketscreener.com
Quest Diagnostics (DGX) Q1 2026 Earnings Call Transcript - Fortune
Quest Diagnostics stock heads into the open after a flat close - AD HOC NEWS
Quest Diagnostics stock gains on strong second quarter figures and Medicare survey impact - AD HOC NEWS
Quest Diagnostics stock heads into the open after a strong recent gain - AD HOC NEWS
Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
96% say lab tests matter as Medicare cuts approach - Stock Titan
A Look at Quest Diagnostics Inc (DGX) After 3.9% Gain -- GF Value $196.33 vs Price $247.08 - GuruFocus
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Why Quest Diagnostics Incorporated (DGX) Stock Is Up Today - Quiver Quantitative
Quest Diagnostics Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Quest Diagnostics Has Carved Out a Narrow Moat on Its Attractive Cost Structure - Morningstar
Quest Diagnostics Inc. stock underperforms Thursday when compared to competitors - MarketWatch
QUEST DIAGNOSTICS INC : UBS RAISES TARGET PRICE TO $245 FROM $232 - webull.com
Quest Diagnostics Announces Apple Health App Users to Be Able to Order Labs from Quest Diagnostics - marketscreener.com
Apple Health users can buy Quest lab tests for $119 later this year - Stock Titan
UBS raises Quest Diagnostics stock price target on durable volumes By Investing.com - Investing.com Canada
UBS Adjusts Quest Diagnostics Price Target to $245 From $232, Maintains Neutral Rating - marketscreener.com
Quest Diagnostics CEO Sells 10,000 Shares for $2.4 Million - Yahoo Finance
Quest Diagnostics stock edges lower near 52-week highs after solid Q2 growth - ad-hoc-news.de
Man Group takes new $495K stake in Quest Diagnostics as stock nears record high - app.dealroom.co
Quest Diagnostics stock holds steady as investors await next earnings update - ad-hoc-news.de
Quest’s Expanded Alzheimer’s and Wellness Testing Push Might Change The Case For Investing In DGX - Yahoo Finance
CEO of Quest Diagnostics (NYSE: DGX) sells 10,000 shares - Stock Titan
Quest Diagnostics Insider Sold Shares Worth $2,427,200, According to a Recent SEC Filing - marketscreener.com
Quest Diagnostics stock gains as investors focus on growth and fair value - AD HOC NEWS
Quest Diagnostics stock trades near 52-week high as kidney testing deal lifts valuation - AD HOC NEWS
Quest Diagnostics (NYSE: DGX) insider plans new sale after June $1.9M trade - Stock Titan
Quest Diagnostics SVP & general counsel sells $5.5m in shares - Investing.com Nigeria
Quest Diagnostics SVP & general counsel sells $5.5m in shares By Investing.com - Investing.com South Africa
Quest Diagnostics Inc. stock underperforms Monday when compared to competitors - MarketWatch
Quest Diagnostics (DGX) Stock Analysis: Navigating Growth Amidst a Competitive Landscape - DirectorsTalk Interviews
Quest Diagnostics stock holds steady as investors await fresh earnings catalysts - AD HOC NEWS
Quest Diagnostics (NYSE: DGX) holder to sell 22,677 shares - Stock Titan
0.34%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):